Before your visit.
Take the brain fog self-check and answer a few safety questions online. Our clinical team reviews them before you book.
The Program
How a Neuon program works
One standard path for everyone. Your plan is set by a neurologist and measured from the first visit.
First visit, about 90 minutes.
A safety screen, your history and baseline measures of thinking speed, attention and, if relevant, movement. We find your personal stimulation level by gently stimulating the motor area of the brain and watching for a small finger movement. Every session after that is set from this number.
Weeks 1 and 2: the induction course.
Ten sessions of about 30 minutes, five days a week, at the same time each day. You sit in a chair, awake, and can go back to your day afterward.
Day 14: your first results.
We repeat your baseline measures and review the change with you the same day.
Months 1 and 3: check points.
We measure again and decide together on next steps.
If the first protocol does not help.
Our pricing includes a change to a different stimulation protocol for one more course. This is a pricing term, not a promise of results.
After that: maintenance.
Either a monthly plan, or a five day booster week every three months for people who travel. Some Parkinson's trials kept their benefit with monthly sessions after the first course, but no study has compared schedules. We will tell you what our own data show.
Evidence
What the research says
Transcranial magnetic stimulation (TMS) is cleared by the FDA for major depression, OCD, smoking cessation and anxious depression. Its use for Parkinson's disease and for brain fog is off-label, which means a physician may offer it but the FDA has not reviewed it for those uses.
In Parkinson's disease, a 2026 review of 16 systematic reviews found that high-frequency stimulation over the motor areas on both sides of the brain probably improves movement symptoms. The benefit was largest with repeated sessions and in several trials lasted weeks to months.
Smaller studies show early signals for freezing of gait, speech and swallowing, mood and thinking. Most studies are small, and the best schedule for ongoing sessions is not yet known.
For brain fog, research is early. Most studies are small and come from long COVID. In mild cognitive impairment, a 2025 review of 80 studies found short-term benefits for overall thinking.
Results vary from person to person. We track every patient's outcomes and share them with you.
References
- Mendonça MD et al. Repetitive transcranial magnetic stimulation as adjunctive treatment in Parkinson's disease: an umbrella and scoping review. Brain Communications, 2026.
- Zhang X et al. Non-invasive brain stimulation and walking and balance in Parkinson's disease. Frontiers in Aging Neuroscience, 2023.
- Effects of non-invasive brain stimulation on cognitive and functional abilities in MCI and dementia. Journal of Psychiatric Research, 2025.
- Rossi S et al. Safety and recommendations for TMS use. Clinical Neurophysiology, 2021.
Safety
Is TMS right for me?
TMS is not suitable for everyone. People with a pacemaker, cochlear implant, brain stimulator or metal in the head (other than dental work) usually cannot have it. A history of seizures needs a doctor's review. We confirm safety at your first visit.
In a review of 77 studies with 1,137 people with Parkinson's disease, no seizures were reported. Side effects were uncommon and mostly mild, such as headache or scalp discomfort.
Neuon services are self-pay. Off-label treatment is provided by licensed physicians after an in-person evaluation and written consent.